Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer
Neurol 91:e985-e994, Touat, M.,et al, 2018
Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018
Dropped Head Syndrome: Report of Three Cases During Treatment with a Mek Inhibitor
Neurol 79:1929-1932, Chen, X.,et al, 2012
Longitudinal Assessment of Oxaliplatin-Induced Neuropathy
Neurol 77:980-986, Burakgazi, A.Z.,et al, 2011
Lhermitte's Sign Following Chemotherapy with Docetaxel
Neurol 50:563-564, van den Bent,M.J.,et al, 1998
Reversible Periph Neuropathy Induced by Single Admin of High-Dose Paclitaxel
Neurol 51:868-870, Iniquez,C.,et al, 1998
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996
Peripheral Neurotoxicity Induced by Docetaxel
Neurol 46:104-108, 21996., Hilkens,P.H.E.,et al, 1996
Motor Neuropathy Due to Docetaxel and Paclitaxel
Neurol 47:115-118, Freilich,R.J.,et al, 1996
Vinorelbine Neurotoxicity:Clinical and Neurophysiological Findings in 23 Patients
JNNP 61:409-411, Pace,A.,et al, 1996
Assoc of Myasthenia Gravis with Extrathymic Hodgkin's Lymphoma:Resol of Myasth Sympt Following Antineopl Therapy
Neurol 45:1019, Abrey,L.E.&Askanas,V., 1995
Peripheral Neuropathy from Taxol and Cisplatin Combination Chemotherapy:Clinical and Electrophysiological Studies
Ann Neurol 35:304-311, Chaudhry,V.,et al, 1994
Taxol Neuropathy:Electrodiagnostic and Sural Nerve Biopsy Findings
Arch Neurol 51:726-729, Sahenk,Z.,et al, 1994
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Prevention of Cisplatin Neurotoxicity with an ACTH (4-9) Analogue in Patients with Ovarian Cancer
NEJM 322:89-94, 126-1271990., Gerritsen Van Der Hoop,R.,et al, 1990
Suramin-Induced Polyneuropathy
Neurol 40:954-960, LaRocca,R.V.,et al, 1990
Taxol Produces a Predominantly Sensory Neuropathy
Neurol 39:368-373, Lipton,R.B.,et al, 1989
Unusual Presentation of Cis-Platinum Neuropathy
Neurol 38:488-490, Mollman,J.E.,et al, 1988
Regional Nerve Injury After Intra-Arterial Chemotherapy
Neurol 37:834-837, Castellanos,A.M.,et al, 1987
Cisplatin Neuropathy with Lhermitte's Sign
JNNP 49:96-99, Dewar,J.,et al, 1986
Cisplatin Neuropathy
Cancer 54:1269-1275, Thompson,S.W.,et al, 1984
Diagnosis & Treatment of Lumbosacral Plexopathies in Patients with Cancer
Arch Neurol 41:1282-1285, Pettigrew,L.C.,et al, 1984
Neurotoxic Effects of Cisplatin Therapy
Arch Neurol 39:719-720, Walsh,T.J.,et al, 1982
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Neuropathy Due to Cytosine Arabinoside
BMJ 2:652-653, Russell,J.A.,et al, 1974
Vincristine Neurotoxicity
Ann Int Med 80:733-737, Rosenthal,S.,et al, 1974
The Neuromyopathy of Vincristine in Man, Clinical, Electrophysiol & Pathological Studies
J Neurol Sci 10:107-131, Bradley,W.G.,et al, 1970
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
A 66-Year-Old Woman With Progressive Encephalopathy and Bilateral Hearing Loss
Neurol 100:254-258, Rivers,D.,et al, 2023
New-Onset Diplopia and Headache in a Patient with Metastatic Breast Cancer
Neurol 100:927-931, Rizzo,S.A.,et al, 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
Clinicopathologic Conference, Plasm-Cell Myeloma Post-Transplant Lymphoproliferative Disorder
NEJM 386:2508-2516, Case 20-2022, 2022
Imaging Findings in Children Presenting with CNS Nelarabine Toxicity
AJNR 43:1802-1809, Serrallach,B.L.,et al, 2022
Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions
Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021
A 59-Year-Old Woman Presenting with Diplopia, Dysarthria, Right-sided Weakness, and Encephalopathy
Neurol 97:e859-e864, Manzano, G.S.,et al, 2021
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
Chemotherapy-Associated Hyperammonemic Encephalopathy
Neurol 94:e874-e877, Briard, J.N.,et al, 2020
Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020
Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020
Acute Toxic Leukoencephalopathy: Etiologies, Imaging Findings, and Outcomes in 101 Patients
AJNR 40:267-275, Ozutemiz, C.,et al, 2019
Delayed Complications of Cranial Irradiation
www.UptoDate.com, May, Dietrich, J.,et al, 2019
Neurolymphomatosis
Neurol 93:e1229-e1230, DeBoer, S.R.,et al, 2019